Provided by Tiger Trade Technology Pte. Ltd.

INCANNEX HEALTHCARE LTD

3.21
-0.0400-1.23%
Post-market: 3.220.0125+0.39%19:58 EDT
Volume:58.21K
Turnover:189.91K
Market Cap:40.27M
PE:-1.94
High:3.33
Open:3.32
Low:3.20
Close:3.25
52wk High:15.00
52wk Low:2.49
Shares:12.54M
Float Shares:10.18M
Volume Ratio:0.73
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6556
EPS(LYR):-40.8237
ROE:-47.80%
ROA:-24.58%
PB:0.60
PE(LYR):-0.08

Loading ...

Incannex Healthcare Inc: Expects Additional a$5.1 Mln in R&D Tax Incentive Proceeds in 2026

THOMSON REUTERS
·
Jun 10

Incannex Healthcare receives A$6.04 million Australia R&D tax incentive refund

Reuters
·
Jun 10

Alliance Global Partners initiates Incannex coverage with Buy rating, US$18 price target

Reuters
·
Jun 09

Incannex Healthcare Initiated at Buy by Alliance Global Partners

Dow Jones
·
Jun 08

Incannex Healthcare Inc : Alliance Global Partners Initiates Coverage With Buy Rating; Target Price $18

THOMSON REUTERS
·
Jun 08

Incannex Q3 FY26 operating loss narrows 19% to USD 4.05 million

Reuters
·
May 15

Incannex commences DReaMzz clinical study of IHL-42X in OSA

TIPRANKS
·
May 15

Incannex Healthcare Inc - Commences Dreamzz Clinical Study of Ihl-42X for Obstructive Sleep Apnea

THOMSON REUTERS
·
May 14

Incannex says Phase 2 RePOSA trial shows IHL-42X reduces sleep apnea severity

Reuters
·
May 12

Incannex Healthcare Inc expected to post a loss of 93 cents a share - Earnings Preview

Reuters
·
May 11

Incannex backs White House order to speed access to psychedelic mental health treatments

Reuters
·
Apr 22

Incannex says Phase 2 trial shows PSX-001 cuts GAD anxiety scores vs placebo

Reuters
·
Apr 22

Incannex Healthcare Inc - Psx-001 Shows Statistically Significant Improvements in Phase 2 Trial

THOMSON REUTERS
·
Apr 22

Incannex Healthcare Psx-001 Program Aligns With White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness

THOMSON REUTERS
·
Apr 22

Two new option listings on April 16th

TIPRANKS
·
Apr 16